New Pyrimidinone and Fused Pyrimidinone Derivatives as Potential Anticancer Chemotherapeutics
- 6 June 2012
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 345 (9) , 729-738
Abstract
A series of novel substituted pyrimidinones and fused pyrimidinones (compounds 3–18) were synthesized starting with oxiranylmethanone 2. The in vitro cytotoxicity against a human breast adenocarcinoma (MCF‐7) cell line was investigated and most of the tested compounds showed potent cytotoxic activity against the MCF‐7 cell line comparable to the activity of the commonly used anticancer drug cisplatin. Treatment of MCF‐7 cells with increasing doses (2, 5, 10, and 20 µg/mL) of the tested compounds revealed that the activity of superoxide dismutase and the level of hydrogen peroxide were significantly increased, while the activities of catalase and glutathione peroxidase and the levels of reduced glutathione were significantly lowered compared with control MCF‐7 cells. In general, derivatives 11 and 16 revealed the highest anticancer activity among the tested compounds.Keywords
This publication has 40 references indexed in Scilit:
- Comparative Computational Studies of 3,4-Dihydro-2,6-diaryl-4-oxo-pyrimidine-5-carbonitrile Derivatives as Potential Antinociceptive AgentsMolecules, 2012
- Some Novel Thiopyrimidine Nucleoside Analogs: Synthesis and In Vitro Antimicrobial EvaluationSynthetic Communications, 2011
- A Facile Synthesis and Anti-Avian Influenza Virus (H5N1) Screening of Some Novel Pyrazolopyrimidine Nucleoside DerivativesNucleosides, Nucleotides & Nucleic Acids, 2010
- Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activitiesEuropean Journal of Medicinal Chemistry, 2009
- Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin–mimetic activitiesJournal of Inorganic Biochemistry, 2006
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
- Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 1994
- Inactivation of ribonucleotide reductase by nitric oxideBiochemical and Biophysical Research Communications, 1991
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988